相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness
Tania Gamberi et al.
MEDICINAL RESEARCH REVIEWS (2022)
Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non-small cell lung cancer
Qingyuan Huang et al.
SCIENCE ADVANCES (2022)
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Cong Luo et al.
ORPHANET JOURNAL OF RARE DISEASES (2022)
Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma
Ruoyan Cao et al.
FRONTIERS IN ONCOLOGY (2022)
Ingenuity pathway analysis of α-synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseases
Sharad Kumar Suthar et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)
Beyond controlling cell size: functional analyses of S6K in tumorigenesis
Xueji Wu et al.
CELL DEATH & DISEASE (2022)
ROS-mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC
Xiang Cao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma
Sinan Xiong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited
ElHusseiny M. M. Abdelwahab et al.
APOPTOSIS (2021)
PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review)
Daniela Miricescu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Recent Updates on the Involvement of PI3K/AKT/mTOR Molecular Cascade in the Pathogenesis of Hyperproliferative Skin Disorders
Laura Mercurio et al.
FRONTIERS IN MEDICINE (2021)
Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations
Elhusseiny Mohamed Mahmoud Abdelwahab et al.
FRONTIERS IN ONCOLOGY (2021)
Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors
Yiqun Xia et al.
THERANOSTICS (2021)
Pediatric low-grade glioma in the era of molecular diagnostics
Scott Ryall et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
NRF2, a Transcription Factor for Stress Response and Beyond
Feng He et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
Salihanur Darici et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Which Antioxidant System Shapes Intracellular H2O2 Gradients?
Natalie M. Mishina et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
Tian Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
mTOR Signalling in Head and Neck Cancer: Heads Up
Fiona H. Tan et al.
CELLS (2019)
Exogenous Cytokine-Free Differentiation of Human Pluripotent Stem Cells into Classical Brown Adipocytes
Masako Oka et al.
CELLS (2019)
Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug
Xiaonan Zhang et al.
BIOCHIMIE (2019)
Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target
E. M. M. Abdelwahab et al.
ONCOGENE (2019)
TSC2 genetic variant and prognosis in non-small cell lung cancer after curative surgery
Yong Hoon Lee et al.
THORACIC CANCER (2019)
Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study
Janet Bee et al.
THORAX (2018)
Prognostic roles of mRNA expression o f peroxiredoxins in lung cancer
Liangyuan Chen et al.
ONCOTARGETS AND THERAPY (2018)
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice Andre et al.
CANCER DISCOVERY (2017)
The role of peroxiredoxins in cancer
Arianna Nicolussi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Genetics of renal cancer: focus on MTOR
Arindam P. Ghosh et al.
AGING-US (2016)
Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2- Tumor Related to Lymphangioleiomyomatosis
Michael Yue et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Endoplasmic Reticulum Stress and Associated ROS
Hafiz Maher Ali Zeeshan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
Alexandr V. Bazhin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
Yujun Hao et al.
NATURE COMMUNICATIONS (2016)
Impaired Mitochondrial Dynamics And Mitophagy In Neuronal Models Of Tuberous Sclerosis Complex (vol 17, pg 1053, 2016)
Darius Ebrahimi-Fakhari et al.
CELL REPORTS (2016)
Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide
Venkat R. Pannala et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Profiling of cell stress protein expression in cardiac tissue of cardiosurgical patients undergoing remote ischemic preconditioning: implications for thioredoxin in cardioprotection
Karina Zitta et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA
Suleyman Aydin
PEPTIDES (2015)
Auranofin: Repurposing an Old Drug for a Golden New Age
Christine Roder et al.
DRUGS IN R&D (2015)
Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy
Sara Alves et al.
ONCOTARGET (2015)
Tissue thioredoxin reductase-1 expression in astrocytomas of different grades
Hasan Esen et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease
Stewart Siyan Cao et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Targeting antioxidants for cancer therapy
Andrea Glasauer et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas
Hamid Bur et al.
HISTOPATHOLOGY (2014)
A Paradoxical Chemoresistance and Tumor Suppressive Role of Antioxidant in Solid Cancer Cells: A Strange Case of Dr. Jekyll and Mr. Hyde
Jolie Kiemlian Kwee
BIOMED RESEARCH INTERNATIONAL (2014)
A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia
Noa Tejman-Yarden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell death
Stephanie De Simoni et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway
H. Kato et al.
CELL DEATH AND DIFFERENTIATION (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
Jie Zheng
ONCOLOGY LETTERS (2012)
Peroxiredoxin 5: Structure, Mechanism, and Function of the Mammalian Atypical 2-Cys Peroxiredoxin
Bernard Knoops et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
mTOR Inhibitors in Advanced Renal Cell Carcinoma
Martin H. Voss et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1
Martha L. Slattery et al.
CARCINOGENESIS (2010)
Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: Implications for future therapeutic approaches
Stephen M. Schleicher et al.
DRUG RESISTANCE UPDATES (2010)
Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis
Marjo Pylvas et al.
EUROPEAN JOURNAL OF CANCER (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
mTOR Signaling in Lymphangioleiomyomatosis
Arnold S. Kristof
LYMPHATIC RESEARCH AND BIOLOGY (2010)
The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein
Zhaohui Feng et al.
TRENDS IN CELL BIOLOGY (2010)
Assembly of the oxidative phosphorylation system in humans: What we have learned by studying its defects
Erika Fernandez-Vizarra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Endoplasmic reticulum stress in disease pathogenesis
Jonathan H. Lin et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+
Stephanie De Simoni et al.
NEUROSCIENCE LETTERS (2008)
A chemical method for fast and sensitive detection of DNA synthesis in vivo
Adrian Salic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13
Gustavo G. Fernandez-Ranvier et al.
WORLD JOURNAL OF SURGERY (2008)
Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms
Heidi Kenerson et al.
HUMAN PATHOLOGY (2007)
GRP78 induction in cancer: Therapeutic and prognostic implications
Amy S. Lee
CANCER RESEARCH (2007)
Rapamycin: An anti-cancer immunosuppressant?
BK Law
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer:: The role of promoter methylation of TSC genes
WG Jiang et al.
EUROPEAN JOURNAL OF CANCER (2005)
Peroxiredoxin 5 expression in the human thyroid gland
AC Gérard et al.
THYROID (2005)
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats
H Nishitoh et al.
GENES & DEVELOPMENT (2002)
Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate
MS Seo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)